ClinicalTrials.gg
CompletedNCT06930469Updated Apr 16, 2025

Shared Decision-Making Structured Team Model for Critical Maternal Care in OB-GYN ICU

An interventional study of structured team model with shared decision-making and conventional multidisciplinary resuscitation care in Critical Illness and Pregnant Women, sponsored by Ying Wang. Completed at 1 site in China. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2025-04-16.

Sponsored by Ying Wang · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled Jan 2023, registered Mar 2025).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

A randomized controlled trial was conducted with 100 critically ill pregnant women admitted to our hospital's obstetrics ICU between January 2023 and December 2024. Participants were allocated via random number table to either the control group receiving conventional multidisciplinary resuscitation care (n=50) or the observation group receiving the structured team model with shared decision-making (n=50). Comparative outcomes included resuscitation efficiency indicators (pre-hospital response time, intrahospital transport duration, emergency supply preparation time), complication rates, family psychological status measured by Hospital Anxiety and Depression Scale (HADS), and family satisfaction assessments

02

Conditions studied

  • Critical Illness
  • Pregnant Women

Browse trials for

03

In context

Critical Illness

1,787 studies on the registry are indexed under Critical Illness; 445 are open to participants now.

This study's enrollment of 100 is above the median of 90 across 930 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Ying Wang is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Meeting diagnostic criteria for critical obstetric conditions:

    1. Amniotic fluid embolism
    2. Postpartum hemorrhage
    3. Emergency cesarean section was performed, etc
  • Age ≥18 years
  • Gestational age >20 weeks
  • Patient's family/legal representative capable of normal communication and providing signed

Exclusion criteria

Exclusion Criteria:

  • Pre-existing primary hematologic disorders:
  • Fetal congenital anomalies confirmed by prenatal imaging
  • Active malignant tumors (except carcinoma in situ)
  • Severe organ dysfunction:
  • Altered mental status (GCS ≤12) or documented psychiatric disorders
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    structured team model with shared decision-making

    Behavioral: structured team model with shared decision-making

  • Other
    conventional multidisciplinary resuscitation care

    Behavioral: conventional multidisciplinary resuscitation care

Interventions

  • Behavioralstructured team model with shared decision-making

    Structured team model based on shared decision-making model: ① Maternal Critical Care Review: Pre-hospital (prenatal checkup): Obstetricians and nurses conduct regular prenatal checkups for mothers, identify high-risk mothers, and set up high-risk maternal health records. Referral: Critically ill pregnant women establish a green channel for timely referral to the obstetrics department or ICU, and contact the relevant personnel of the structured management team. Assessment: The multidisciplinary team conducts a comprehensive assessment of the extent of the maternal condition, vital signs, and laboratory test results. Identification: Identify the main causes of critical maternal illness and potential risks, such as hemorrhage, infection, and organ failure. Rescue plan: according to the assessment results, formulate a personalized rescue plan and clarify the responsibilities and tasks of each department. Monitoring: real-time monitoring of maternal vital signs and changes in condition, a

  • Behavioralconventional multidisciplinary resuscitation care

    The observation group implemented a structured team model based on a shared decision-making model, which operated as follows: (1) Constructing a structured management team: multidisciplinary medical and nursing staff, including obstetricians, ICU doctors, obstetric nurses, ICU nurses, head nurses, anesthesiologists, ultrasonographers, and family members of the patient's main companions, are divided into small teams according to their functions, and each small team has a team leader who is responsible for the coordination of the overall situation and the rapid coordination of information. Obstetricians and ICU doctors are responsible for life support, obstetric evaluation, condition monitoring and development of resuscitation plan for critically ill mothers. Anesthesiologists are responsible for anesthesia management, pain control and intraoperative resuscitation support. The nurse manager coordinates the nursing team to ensure the standardization of rescue care. Obstetrician and ICU nu

06

What researchers measure

Primary outcomes

  1. Maternal mortality in critically ill women

    The mortality of critically ill parturients during hospitalization and the number of deaths/total number of parturients were recorded.

    Time frame: 28 days postpartum

  2. Neonatal survival rate

    counting the survival of newborns within seven days after birth

    Time frame: Seven days after birth

Secondary outcomes

  1. pre-hospital response time

    The pre-hospital emergency response time was recorded

    Time frame: 1 day

  2. intrahospital transport duration

    The intra-hospital transport time was recorded

    Time frame: 1 day

  3. emergency supply preparation time

    The preparation time of first aid items was recorded

    Time frame: 1 day

  4. complication rates

    Complications such as fever, infection and pelvic hematoma were recorded during the rescue period.

    Time frame: 28 days postpartum

  5. family psychological status measured

    The Hospital Anxiety and Depression Scale (HADS) was used for evaluation, which consists of two subscales, including anxiety and depression, each with 7 items. The scale is scored on a 4-point scale, and the total score is 0-21. The higher the score, the more serious the anxiety or depression.

    Time frame: 28 days postpartum

  6. Satisfaction of family members

    The Chinese version of critical care family satisfaction survey (CCFSS) was used for evaluation. The scale consisted of 5 dimensions and 20 items, including disease assurance, access to information, acceptance, support, and comfort. There were 4, 5, 3, 6, and 2 items in sequence, and a 5-point scale was used. The total score ranged from 20 to 100, with higher scores indicating higher family satisfaction.

    Time frame: 28 days postpartum

07

Study locations

1 site
  • Nantong First People's Hospital
    Nantong, Jiangsu 226000, China
08

References and documents

Individual participant data

Plan to share: No — We may have further research, and we may not consider releasing the research data until the results are announced

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2023 to primary completion in Dec 2024, 23 months.

Of 405 non-industry interventional studies with no phase under Critical Illness, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's 23 months is close to that.

Counting every sponsor, half of 409 studies reached it within 21 months; a quarter within 11 and three quarters within 40.

Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2025
First posted
Apr 16, 2025
StartActual
Jan 1, 2023
Primary completionActual
Dec 22, 2024
CompletionActual
Feb 1, 2025
Last update
Apr 16, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06930469
Lead sponsor
Ying Wang
Responsible party
Ying Wang (Clinical Professor, Nantong First People's Hospital) — Sponsor-investigator
First posted
Apr 16, 2025
Start date
Jan 1, 2023
Primary completion
Dec 22, 2024
Completion
Feb 1, 2025
Last update
Apr 16, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion